Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3301–3350 of 18397
Thomas Klinger, who had previously been serving as Senior Manager, Finance and Business Operations, Lockheed Martin Space, is being appointed acting Chief Financial Officer
Chief Executive Officer Marc Bell, Executive Vice President and Chief Financial Officer Adarsh Parekh, Chief Transformation Officer Gary Hobart, and Executive Vice President and Chief Revenue Officer Marco Villa are being separated from the Company
Aware, Inc. (the “Company”) and Robert A. Eckel, the Company’s Chief Executive Officer and President and a member of the Company’s Board of Directors (the “Board”), agreed that Mr. Eckel would leave the Company and the Board, effective December 31, 2024.
On October 29, 2024, the Board appointed Eric J. Lindberg, Jr., 53, as Interim President and Chief Executive Officer, effective immediately.
On October 29, 2024, Robert J. Sheedy, Jr. agreed to step down as the Company’s President and Chief Executive Officer and resign as a member of the Board, effective immediately.
the Board appointed Scott E. Huckins as the Company's President and Chief Executive Officer, and elected Mr. Huckins a member of the Board of Directors to fill the vacancy resulting from Mr. Mitchell's departure from the Board, all effective as of January 1, 2025.
the Board appointed Nathan D. Lowe as Vice President, Chief Financial Officer and Treasurer, to fill the vacancy resulting from the appointment of Mr. Huckins as President and Chief Executive Officer, effective as of January 1, 2025.
On October 24, 2024, Lance Mitchell notified the Company that he plans to step down as President and Chief Executive Officer of the Company and as a member of the Company's Board, all effective as of January 1, 2025.
On October 25, 2024, Dr. Scott Koenig, the President and Chief Executive Officer of MacroGenics, Inc. (the “ Company ”) and the Company entered into a separation and consulting agreement, dated October 25, 2024 (the “ Separation Agreement ”), which provides for the terms of Dr. Koenig’s separation from employment, effective February 28, 2025
On October 28, 2024, Michael McDonnell, Chief Financial Officer of Biogen Inc. (the “Company”) notified the Company that he will retire from the Company effective February 28, 2025.
Robin Kramer, the Company’s Chief Accounting Officer and Head of Global Business Services and Treasury has been appointed Chief Financial Officer effective upon Mr. McDonnell’s retirement.
Travis Lan, the Company’s current Executive Vice President and Deputy Chief Financial Officer, will assume the duties of interim Chief Financial Officer on the effective date of Mr. Hagedorn’s separation from service.
On October 30, 2024, Valley National Bancorp (the “Company”) announced that Michael Hagedorn will separate from service as Senior Executive Vice President and Chief Financial Officer of the Company effective as of November 30, 2024.
On October 28, 2024, the Board of Directors appointed Mr. William Hayde, who is the Chairman of the Board, to serve as President/Chief Executive Officer of Nu-Med.
Mr. Colvin submitted his resignation from the positions to which he had been appointed.
On October 27, 2024, Shashank Patel, the Registrant’s Chief Financial Officer, provided notice of his intention to retire from the Registrant effective as of March 15, 2025.
the Company appointed Michael C. Greiner to serve as Interim Chief Executive Officer of the Company.
On October 28, 2024, the Company announced the retirement of Joseph F. Woody as Chief Executive Officer and a member of the Board of Directors of the Company, effective immediately.
On October 30, 2024, Planet Fitness, Inc. (the “Company”) announced the appointment of Jay Stasz, age 57, as Chief Financial Officer (“CFO”) of the Company.
as of November 15, 2024, at which time Tom Fitzgerald will no longer serve as the Company’s principal financial officer.
On October 30, 2024, the Company announced the appointment of Christoph Brackmann, age 51, as the Chief Financial Officer of the Novocure Group, effective January 1, 2025.
On October 29, 2024, Donaldson Company, Inc. (the “Company”) announced the appointment of Brad Pogalz as the Company’s Chief Financial Officer, effective November 1, 2024.
Mr. Pogalz succeeds Scott Robinson, who, on October 25, 2024, gave notice of his retirement from the Company, resigning from the office of Chief Financial Officer effective at the close of business on October 31, 2024, and retiring from his employment effective at the close of business on December 6, 2024.
Following a review by outside counsel, on October 24, 2024, the Board of Directors (the “Board”) of Masimo adopted resolutions to terminate the employment of Masimo’s Chief Executive Officer, Joe Kiani, effective October 24, 2024.
As previously reported, the Board has appointed Michelle Brennan as Interim Chief Executive Officer.
On October 28, 2024, the Board of Directors of the Company (the “Board”) unanimously appointed Rik Powell, the Company’s Senior Vice President, Finance and Investor Relations since June 3, 2024, as the Company’s Chief Financial Officer, effective November 1, 2024
On October 24, 2024, Jarrod Yahes notified Shutterstock, Inc. (the “Company”) of his resignation as Chief Financial Officer of the Company, effective November 1, 2024
on October 23, 2024, Mr. Wolfe transitioned out of such position
the Company appointed Luis Claudio Goldner, a member of the Company’s Board of Directors, as Chief Executive Officer of the Company on such date.
Effective October 23, 2024, Peter Kampian voluntarily resigned as Chief Financial Officer of 4Front Ventures Corp. (the “Company”).
Effective with Mr. Kampian’s departure, Michael Kronberg was appointed interim CFO.
On October 25, 2024, the Company's President and Chief Executive Officer, Andres Reiner, notified the Company's Board of Directors (the "Board") that he intends to retire from his position, effective upon his successor’s appointment as the Company’s Chief Executive Officer.
On October 25, 2024, Mr. Mark Andersen informed FibroBiologics, Inc. (the “Company”) of his decision to voluntarily resign from his position as the Company’s Chief Financial Officer
On October 23, 2024, Elizabeth Ng notified the Company’s Board of Directors that she would be taking a sabbatical for personal reasons.
Director, M. Michelle Berrey was appointed to act as Interim Chief Executive Officer, effective immediately.
On October 29, 2024, the board of directors of USA Compression GP, LLC (the "Company"), the general partner of USA Compression Partners, LP (the "Partnership"), appointed Christopher M. Paulsen to the position of Vice President, Chief Financial Officer and Treasurer of the Company, effective November 18, 2024.
Mr. Paulsen will replace G. Tracy Owens as the principal financial officer of the Company, effective November 18, 2024.
On October 24, 2024, Gary J. Grieco stepped down from his position as Chairman of the Board and Chief Executive Officer of the Registrant.
Concurrent with Mr. Grieco stepping down from the position of Chairman of the Board and Chief Executive Officer, the Registrant appointed Arthur E. Abraham, its current CFO of the Registrant and President & CFO of PCT Corporation as the Registrant’s new Chairman of the Board and Chief Executive Officer of the Registrant.
Mengqing Fan was appointed as Chief Financial Officer, Director, Chairman of the Board, President, Secretary, Treasurer.
Jinghua Song was appointed as Chief Executive Officer and Director
Ms. Rentler will cease to serve as CEO and will no longer be an executive officer of the Company, effective as of the end of the current fiscal year (February 1, 2025)
the Company announced that Matt Dunn, currently the Company's Senior Vice President, Finance, will succeed Mr. Magstadt as Chief Financial Officer and Treasurer, effective January 1, 2025.
Brian Magstadt, notified Simpson Manufacturing Co, Inc. (the "Company") on July 25, 2024, that he will retire as Chief Financial Officer and Treasurer, effective December 31, 2024.
On October 25, 2024, the Company’s Board of Directors (the “Board”) took action to appoint Edward Cooper Werner as its next Executive Vice President (“EVP”) and Chief Financial Officer (“CFO”).
Mr. Werner will assume his role effective on the first business day following the filing with the Securities and Exchange Commission of the Company’s Form 10-K for the Company’s 2024 fiscal year and the related retirement of the Company’s current EVP and CFO, Frank Pelzer, consistent with the Company’s public announcement on July 29, 2024.
On August 8, 2024, GlobeStar Therapeutics Corporation, a Wyoming corporation (the “Company”) received notice of the resignation of Robert Chicoski as Chief Financial Officer of the Company.
John Koryl ceased to serve as Chief Executive Officer of the Company and resigned as a member of the Board on the same day.
the Board of Directors (the “Board”) of the Company appointed Rati Sahi Levesque, formerly the Company’s President and Chief Operating Officer, as President and Chief Executive Officer of the Company, effective as of October 28, 2024.
On October 22, 2024, Christopher Condelles notified the board of directors of FS Credit Real Estate Income Trust, Inc. (the “Company”) of his resignation from his position as chief financial officer of the Company effective October 28, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.